Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospital and KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
Janssen Research and Development, Beerse, Belgium.
Sci Rep. 2021 Aug 9;11(1):16172. doi: 10.1038/s41598-021-95715-y.
[F]JNJ-64413739 has been evaluated as PET-ligand for in vivo quantification of purinergic receptor subtype 7 receptor (P2X7R) using Logan graphical analysis with a metabolite-corrected arterial plasma input function. In the context of a P2X7R PET dose occupancy study, we evaluated a minimally invasive approach by limiting arterial sampling to baseline conditions. Meanwhile, post dose distribution volumes (V) under blocking conditions were estimated by combining baseline blood to plasma ratios and metabolite fractions with an MR angiography driven image derived input function (IDIF). Regional postdose V values were compared with corresponding V estimates using a arterial input function (AIF), in terms of absolute values, test-retest reliability and receptor occupancy. Compared to an invasive AIF approach, postdose V values and corresponding receptor occupancies showed only limited bias (Bland-Altman analysis: 0.06 ± 0.27 and 3.1% ± 6.4%) while demonstrating a high correlation (Spearman ρ = 0.78 and ρ = 0.98 respectively). In terms of test-retest reliability, regional intraclass correlation coefficients were 0.98 ± 0.02 for V compared to 0.97 ± 0.01 for V These results confirmed that a postdose IDIF, guided by MR angiography and using baseline blood and metabolite data, can be considered for accurate [F]JNJ-64413739 PET quantification in a repeated PET study design, thus avoiding multiple invasive arterial sampling and increasing dosing flexibility.
[F]JNJ-64413739 已被评估为嘌呤能受体亚型 7 受体 (P2X7R) 的 PET 配体,使用 Logan 图形分析,采用校正代谢物的动脉血浆输入函数进行体内定量。在 P2X7R PET 剂量占有率研究中,我们通过将动脉取样限制在基线条件下,评估了一种微创方法。同时,通过将基线血液与血浆比值和代谢物分数与磁共振血管造影驱动的图像衍生输入函数 (IDIF) 相结合,估算了阻断条件下的分布体积 (V)。根据绝对值、测试-重测可靠性和受体占有率,将基础状态下的 V 值与相应的 V 估计值进行了比较。与侵入性 AIF 方法相比,给药后 V 值和相应的受体占有率仅显示出有限的偏差 (Bland-Altman 分析:0.06 ± 0.27 和 3.1% ± 6.4%),同时具有很高的相关性 (Spearman ρ = 0.78 和 ρ = 0.98)。在测试-重测可靠性方面,V 的区域内组内相关系数为 0.98 ± 0.02,而 V 的区域内组内相关系数为 0.97 ± 0.01。这些结果证实,在重复 PET 研究设计中,通过磁共振血管造影引导,使用基础状态下的血液和代谢物数据,可考虑使用给药后 IDIF 进行 [F]JNJ-64413739 PET 定量,从而避免多次侵入性动脉取样,并增加给药灵活性。